Integer Holdings Corporation
ITGR
Kedudukan dalam Saham
#3838
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Harga Saham
$126.75
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.31B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
18.05%
Negara
US
Perdagangan Integer Holdings Corporation (ITGR)
Kategori
Healthcare
Nisbah P/E bagi Integer Holdings Corporation (ITGR)
Nisbah P/E pada October 2026 TTM: 34.31
Menurut laporan kewangan dan harga saham terkini Integer Holdings Corporation, nisbah P/E semasa (TTM) ialah 34.31. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 36.42.
Sejarah nisbah P/E bagi Integer Holdings Corporation dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 34.31 | -7.62% |
| 2024 | 37.14 | 1.98% |
| 2023 | 36.42 | 6.59% |
| 2022 | 34.17 | 17.13% |
| 2021 | 29.17 | -15.49% |
| 2020 | 34.52 | 26.71% |
| 2019 | 27.24 | 87.26% |
| 2018 | 14.55 | -31.81% |
| 2017 | 21.33 | -85.97% |
| 2016 | 152.06 | 598.09% |
| 2015 | 21.78 | -24.82% |
| 2014 | 28.97 | -125.76% |
| 2012 | -112.49 | -824.88% |
| 2011 | 15.52 | -7.70% |
| 2010 | 16.81 | -48.10% |
| 2009 | 32.39 | 10.54% |
| 2007 | 29.31 | -19.48% |
| 2006 | 36.40 | -34.47% |
| 2005 | 55.54 | 88.56% |
| 2004 | 29.45 | -29.19% |
| 2003 | 41.59 | -49.94% |
| 2001 | 83.08 | -111.38% |
| 2000 | -730.32 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 33.11 | -3.50% |
US
|
|
| 21.39 | -37.67% |
IE
|
|
| 28.94 | -15.64% |
US
|
|
| 17.34 | -49.47% |
US
|
|
| - | - |
DE
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.